Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electrophoresis, Gel, Two-Dimensional | 4 | 2009 | 39 | 0.390 |
Why?
|
| Proteome | 3 | 2014 | 141 | 0.350 |
Why?
|
| Proteomics | 3 | 2014 | 263 | 0.330 |
Why?
|
| Piperazines | 1 | 2008 | 74 | 0.290 |
Why?
|
| Pyrimidines | 1 | 2008 | 131 | 0.280 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 130 | 0.270 |
Why?
|
| Colon | 1 | 2007 | 136 | 0.260 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 263 | 0.220 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 628 | 0.200 |
Why?
|
| Proteins | 1 | 2007 | 730 | 0.180 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 126 | 0.150 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 229 | 0.140 |
Why?
|
| Mucins | 2 | 2014 | 25 | 0.130 |
Why?
|
| Cerebral Revascularization | 1 | 2015 | 30 | 0.120 |
Why?
|
| Endarterectomy, Carotid | 1 | 2015 | 91 | 0.110 |
Why?
|
| Calgranulin A | 1 | 2014 | 5 | 0.110 |
Why?
|
| Calgranulin B | 1 | 2014 | 6 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2015 | 206 | 0.100 |
Why?
|
| Registries | 1 | 2015 | 799 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2014 | 295 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 331 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 461 | 0.090 |
Why?
|
| Cyst Fluid | 1 | 2009 | 5 | 0.080 |
Why?
|
| Pancreatic Cyst | 1 | 2009 | 24 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2008 | 7 | 0.080 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2008 | 8 | 0.080 |
Why?
|
| Imatinib Mesylate | 1 | 2008 | 33 | 0.070 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2008 | 18 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2008 | 39 | 0.070 |
Why?
|
| Methotrexate | 1 | 2008 | 76 | 0.070 |
Why?
|
| Benzamides | 1 | 2008 | 63 | 0.070 |
Why?
|
| Glutathione Transferase | 1 | 2007 | 33 | 0.070 |
Why?
|
| Catalase | 1 | 2007 | 23 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 188 | 0.070 |
Why?
|
| Stroke | 1 | 2015 | 1127 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2007 | 213 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 718 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 1368 | 0.060 |
Why?
|
| Humans | 8 | 2020 | 59374 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2020 | 270 | 0.040 |
Why?
|
| Female | 4 | 2015 | 30720 | 0.030 |
Why?
|
| United States | 2 | 2020 | 7425 | 0.030 |
Why?
|
| Pancreatic Juice | 1 | 2014 | 1 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 2014 | 35 | 0.030 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2014 | 30 | 0.030 |
Why?
|
| Middle Aged | 4 | 2015 | 16312 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2014 | 32 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2015 | 211 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 204 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 1137 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2015 | 241 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 396 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2014 | 106 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 5119 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 300 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1238 | 0.020 |
Why?
|
| Stents | 1 | 2015 | 461 | 0.020 |
Why?
|
| Adult | 3 | 2015 | 15679 | 0.020 |
Why?
|
| Male | 4 | 2015 | 27743 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 1597 | 0.020 |
Why?
|
| Amylases | 1 | 2009 | 11 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2009 | 32 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2009 | 81 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 178 | 0.020 |
Why?
|
| Genes, APC | 1 | 2008 | 9 | 0.020 |
Why?
|
| Leucovorin | 1 | 2008 | 9 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 126 | 0.020 |
Why?
|
| Antidotes | 1 | 2008 | 20 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 57 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2008 | 59 | 0.020 |
Why?
|
| Rituximab | 1 | 2008 | 80 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 245 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 185 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 193 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 583 | 0.020 |
Why?
|
| Aged | 2 | 2015 | 13406 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2008 | 279 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 225 | 0.020 |
Why?
|
| Sex Factors | 1 | 2008 | 935 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 305 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 402 | 0.010 |
Why?
|
| Age Factors | 1 | 2008 | 1504 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 836 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 3067 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 2456 | 0.010 |
Why?
|
| Adolescent | 1 | 2008 | 5835 | 0.010 |
Why?
|